[The treatment of benign prostatic hyperplasia using the Mumie-Vitas preparation].
Overall thirty-eight patients presenting with stage I-II benign prostate hyperplasia received treatment with a new local drug preparation Mumiyo-Vitas, 0.2 g on a once- or twice-daily basis over six months. Effects were studied of the drug on the urologic symptomatology and quality of life of patients presenting with ongoing micturitional disturbances, functional state of detrusor vesicae, prostate volume and urethral resistance. Efficiency of the treatment given was assessed by the International system, uroflowmetry, ultrasonic investigation. Mumiyo-Vitas appeared to be of therapeutic benefit in those patients with subjective and objective symptoms of the urinary bladder obstruction who had innocent prostate hyperplasia.
Andriukhova
N N
NN
D000368:Aged; D002908:Chronic Disease; D004338:Drug Combinations; D004341:Drug Evaluation; D006801:Humans; D006812:Humic Substances; D008297:Male; D008875:Middle Aged; D008903:Minerals; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology; D012074:Remission Induction; D012116:Resins, Plant / Q000627:therapeutic use*; D013607:Tablets; D013997:Time Factors; D014563:Urodynamics / Q000187:drug effects
D004338:Drug Combinations; D006812:Humic Substances; D008903:Minerals; D012116:Resins, Plant; D013607:Tablets; C045109:mumie
Lechenie dobrokachestvennoĭ giperplazii predstatel'noĭ zhelezy preparatom "Mumie-Vitas".